reported that in models adjusted for multiple variables, RBP4 exhibited a positive association with metabolic syndrome and previous cerebrovascular events, suggesting its potential role as an indicator of metabolic complications, and conceivably, atherosclerosis and overt CVD (26). This evidence concerns the gene RBP4 and atherosclerosis.